Indian Pharmaceutical Supplier to Qatar.
Qatar carries the highest per-capita health spend in the GCC and concentrates demand inside a small number of very large buyers: Hamad Medical Corporation (HMC) anchors the public tertiary system with Hamad General, Rumailah, Al Wakra and Al Khor hospitals plus the NCCCR oncology centre; Sidra Medicine runs the women's and children's tertiary service; Primary Health Care Corporation (PHCC) handles the primary-care formulary; and the private sector covers Al Ahli, Al Emadi, Aster Hospital Qatar, Qatar Red Crescent and Doha Clinic Hospital. Products enter through Hamad International Airport (DOH) and Hamad Port, under the Qatar Ministry of Public Health. Our Mumbai regulatory desk files directly with MoPH; our Dubai commercial desk handles day-to-day coordination with Qatari importers, HMC and Sidra tender windows.
MoPH, HMC and the Vision 2030 spend horizon.
The Pharmacy and Drug Control Department inside the Qatar Ministry of Public Health is the single authority for pharmaceutical registration. Submissions are ICH CTD with a Qatar-specific Module 1 covering the letter of authorisation, the GCC price notification and proposed bilingual artwork. The MoPH pricing committee benchmarks against the GCC reference basket and, for innovator references, European list prices; Qatar's willingness to pay above the GCC mean for premium-segment products reflects its higher per-capita health spend, which has consistently been one of the top three rates globally.
Timelines run 10 to 14 months for a WHO-GMP generic with a clean dossier, API DMF and stability covering one year accelerated plus three months real-time. Innovator references and biologics run 16 to 22 months. Qatar implements GHC central-registration approvals directly, so filers with a current GHC authorisation see MoPH issue the local registration inside a compressed cycle. Controlled substances follow MoPH narcotic-control permitting in parallel with product registration; quarterly import quotas require the Qatari importer of record to hold a valid licence.
Arabic labelling is mandatory: bilingual outer carton and Arabic PIL for retail and OTC, with MoPH artwork review and approval before print. Qatar National Vision 2030 has shifted the spend horizon toward premium tertiary-care categories, and the Qatar National Research Fund increasingly co-funds clinical research that pulls through specialist therapeutics (oncology, critical-care, rare-disease lines). That spend profile changes which molecules are worth registering: Qatar is frequently the right market for premium specialty lines that would stall at the GCC reference floor elsewhere.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six capabilities, tuned to a concentrated-buyer market.
MoPH dossier preparation and filing
ICH CTD dossiers with Qatar-specific Module 1, GCC price notification pack, MoPH artwork submission and the GHC-to-MoPH bridge where a central registration is already current. Variations and renewals tracked on a shared calendar with the Qatari importer of record.
HMC and NCCCR tender response
Technical and commercial pack for Hamad Medical Corporation's hospital network and the National Center for Cancer Care and Research (NCCCR): MoPH number, CoA, CoO, GMP, PSUR, stability, Arabic artwork, critical-care and oncology-specific specifications and a price schedule benchmarked for the Qatari tender format.
Sidra and PHCC supply
Sidra Medicine's paediatric and maternal-health formulary and the Primary Health Care Corporation's primary-care list have distinct specifications. We configure paediatric dose forms, syrup stability, bespoke pack sizes and PHCC-compatible primary-care commercial terms on separate submission tracks.
GHC joint registration
Gulf Health Council central-registration dossiers that pull Qatar into a single six-state submission cycle. Particularly efficient for premium specialty lines where the GHC pathway protects the pricing envelope across the harmonised region.
Arabic bilingual artwork
MoPH-compliant Arabic typesetting with native-speaker medical review, outer-carton bilingual layout, PIL translation and artwork proof secured with MoPH before any print run commits.
Critical-care and biologics logistics
Active cold-chain through DOH for monoclonal antibodies, insulins, biosimilars and ICU injectables, with Qatar Airways Cargo's pharmaceutical corridor as the primary airline partner. Jebel Ali bonded positioning available for premium-segment call-off into Doha.
Mumbai to Doha in under four hours on a pharma-dedicated corridor.
Air freight: BOM-DOH is a roughly three-hour-twenty-minute block flight, with Qatar Airways and IndiGo running multiple daily frequencies and Air India Express adding capacity on narrowbody rotations. Qatar Airways Cargo has invested heavily in its pharmaceutical corridor at Hamad International, with a dedicated pharma-handling facility and certified cool-dolly runs from aircraft to CEIV-Pharma warehouse. Door-to-door for ambient cargo clears in two to four working days; cold-chain transits typically see airport-to-airport under 14 hours. DEL-DOH and COK-DOH back up Mumbai for north- and south-India sourced product.
Sea freight: Nhava Sheva to Hamad Port runs a seven-to-nine-day transit with weekly direct sailings from MSC, CMA CGM and Maersk, and biweekly Hapag-Lloyd capacity. Hamad Port's purpose-built container terminals clear paperwork through the Al Nadeeb single-window customs platform. Less-than-container-load consolidation is available for orders under 12 CBM. Bonded stock is less commonly used in Qatar than in the UAE because call-off volumes are smaller and the air corridor is so fast, but Jebel Ali positioning remains a 24-hour option where a buyer wants buffer outside the Qatari customs envelope.
Cold-chain: Envirotainer RAP e2 and RKN e1 for 2-8 degrees active, va-Q-tec passive for 15-25 ambient, and continuous temperature logging on every consignment above USD 20,000 invoice value. Qatar Airways' IATA CEIV-Pharma certification covers the full airport handling chain, from ramp to Hamad International's pharma warehouse, so excursion risk on the Doha leg is lower than on most Gulf alternatives. Summer tarmac heat remains a consideration; night-arrival slots are preferred where the shipment contains biologics or monoclonal antibodies.
Payment terms: TT 30% advance and 70% against scanned BL for first-time customers, or sight LC through Qatar National Bank, Commercial Bank of Qatar or HSBC Qatar. Repeat customers move to open account at 30 to 90 days after five clean shipments, subject to credit-insurer cover. Institute Cargo Clauses A insurance, door-to-door.
What the HMC, Sidra and PHCC formularies actually pull.
Oncology and supportive care sit at the top of the HMC draw. The National Center for Cancer Care and Research runs a full solid-tumour and haematology service, and trastuzumab, rituximab, bevacizumab and pertuzumab biosimilars move through the NCCCR pharmacy alongside pegfilgrastim, granisetron and high-dose methotrexate support. Critical-care injectables are the second pillar: HMC's tertiary ICU footprint turns over significant volume of noradrenaline, vasopressin, propofol, midazolam, fentanyl and the full resuscitation formulary, with higher bed-turnover than most GCC peers.
Cardiometabolic remains a persistent third. Adult diabetes prevalence in Qatar hovers around 17%, and the cardiovascular formulary (statins, SGLT2 inhibitors, DPP-4 inhibitors, ARBs, beta-blockers, long-acting insulins) moves through both HMC outpatient pharmacies and the PHCC primary-care network. Sidra Medicine adds a distinct paediatric and maternal-health layer: paediatric-dose antibiotics, antiepileptics, paediatric oncology and maternal-health injectables, all on a stricter stability and pack-size profile than adult-formulary equivalents.
Ophthalmology, dermatology, endocrinology and specialty gastroenterology round out the roster. Every line ships with MoPH-compliant bilingual labelling, GCC-price-compliant commercial schedules and CoA-per-batch documentation.
A Doha importer took on three oncology biosimilars and two supportive-care injectables with M Care across 2024-25, targeting an NCCCR framework response. We delivered the full MoPH-filed technical pack in 11 weeks from brief to submission, positioned a 90-day cold-chain buffer at Jebel Ali ready for rolling call-off, and landed 26 consignments into DOH across 13 months with zero temperature excursions on the CEIV-Pharma-certified corridor. Weighted landed cost ran 28% below the previous European-reference benchmark, enabling the importer to hold the tender price through the first renewal cycle.
Why Indian pharma, why M Care, and what a Qatari buyer actually receives.
Qatar is the most concentrated pharmaceutical demand in the GCC: a few very large public buyers dominate, the private sector is smaller than in the UAE or KSA, and the per-capita spend is the highest in the region. Indian manufacturing serves this shape well because it delivers WHO-GMP-grade capacity at a cost basis that allows both aggressive tender pricing on the HMC public list and premium positioning where Sidra or private-sector buyers pay above the GCC reference for specialist lines. Roughly a fifth of global generic finished-dosage-form volume comes out of Indian plants, and the ICH-aligned stability, eCTD dossiers and English documentation move through MoPH without translation friction.
The harder question is which Indian house to work with. MoPH rejects incomplete dossiers firmly, and HMC's tender operations team has long memory for suppliers who failed a supply commitment. M Care's Mumbai head office holds the regulatory and CMC engine, with eCTD readiness from the first submission, a pharmacovigilance function staffed to respond inside MoPH's query windows, and stability protocols that match the climactic conditions Qatar actually runs. Our Dubai commercial desk sits across a three-hour flight from Doha, manages the importer-of-record relationship end to end, and moves bonded stock into HMC call-off windows when the tender is awarded.
Three specifics distinguish the relationship. First, a single named account manager who owns the file from RFQ through re-order, through NCCCR oncology tender rolls, and through the inevitable artwork variation when MoPH updates the bilingual specification. Second, GHC readiness for the premium specialty lines that justify a six-state launch; a GHC-anchored Qatar registration preserves the pricing envelope better than a single-market MoPH filing. Third, realistic logistics. We do not claim same-day air freight and we do not over-promise on cold-chain: we quote the CEIV-Pharma corridor because it is the route we actually run, and we back-up position at Jebel Ali because that is the fallback that works.
A practical note for premium-segment Qatari buyers: the higher per-capita willingness to pay does not mean MoPH pricing review is lenient, it means the review is more detailed. Bring a molecule with a credible clinical differentiation story and the pricing committee will engage; bring a me-too generic with thin data and the timeline extends. We advise on which end of that spectrum your molecule sits on the first call.
Qatar pharmaceutical import: common questions.
Which authority registers pharmaceutical products in Qatar?
The Pharmacy and Drug Control Department inside the Qatar Ministry of Public Health (MoPH). MoPH issues the registration number that appears on every imported commercial pack. Dossiers follow ICH CTD with a Qatar-specific Module 1 and a GCC price notification.
How long does MoPH registration typically take?
Ten to fourteen months for a WHO-GMP-sourced generic with a clean dossier, API DMF and stability covering one year accelerated plus three months real-time. Innovator references and biologics run 16 to 22 months. A current GHC central registration usually compresses MoPH review.
How do Hamad Medical Corporation tenders work?
HMC runs centralised framework tenders for its hospital network (Hamad General, Rumailah, Al Wakra, Al Khor, NCCCR). Successful bidders supply against call-off orders over one to three years. The technical pack requires MoPH-registered SKUs, CoA, CoO, GMP, PSUR, stability, Arabic artwork and a price schedule benchmarked for the Qatari tender format.
Does Qatar accept GCC joint registration?
Yes, fully. Qatar implements GHC central-registration approvals through MoPH directly, so a current GHC authorisation avoids a duplicate Qatar-specific submission cycle. We file through GHC where the molecule's commercial life justifies the six-state launch.
Is Arabic labelling mandatory for Qatar?
Yes. Outer carton bilingual Arabic and English, Arabic patient information leaflet for retail and OTC lines, and MoPH artwork approval before any print run. We commission the Arabic typesetting, run native-speaker medical review and secure MoPH sign-off as part of the pre-shipment pack.
What cold-chain guarantees do you offer on BOM-DOH shipments?
Validated Envirotainer RAP e2 or RKN e1 for 2-8 degrees active, va-Q-tec passive for 15-25 ambient, continuous temperature logging, and a Qatar Airways CEIV-Pharma handling corridor at Hamad International. Airport-to-airport cold transits run under 14 hours. Insurance on Institute Cargo Clauses A, door-to-door.
Can M Care supply Sidra Medicine's paediatric formulary?
Yes. Sidra's paediatric and maternal-health formulary needs paediatric-dose specifications, tighter stability windows and specific pack sizes. We configure these on a separate submission track so the Sidra technical pack is not a retrofit of an adult-formulary dossier.
Why buyers choose M Care for the India → Qatar corridor.
Qatar MoPH DPA fluency
Dossiers built to the exact format Qatar MoPH DPA reviews, not a generic CTD dump. We know which modules get scrutinised first, which stability data triggers queries, and which legalisation and apostille chain the submission needs to clear on the first pass.
Logistics you can schedule around
BOM → DOH direct air for time-critical orders, and Hamad Port for high-volume ambient sea freight. Cold-chain SKUs run on validated containers with continuous temperature logging. Consolidation at origin so you order by molecule, not by MOQ.
Commercial discipline, one point of contact
USD invoicing with clear FX-clause language, LC / TT / open-account progression as the relationship proves out, 18 therapeutic areas on one PO, and one named account manager from enquiry through clearance in Qatar.
Top categories we ship to Qatar
Anti-infectives
Penicillins, cephalosporins, carbapenems, antivirals, antimalarials — 1,800+ hospital and retail lines.
Cardiovascular
Antihypertensives, statins, anticoagulants, antiarrhythmics and heart-failure lines.
Oncology
Cytotoxics, targeted therapy and supportive care — bortezomib, docetaxel, paclitaxel, gemcitabine.
Diabetes & endocrine
Insulins, oral antidiabetics, thyroid and hormonal therapy — 470+ lines across the spectrum.
CNS & neurology
Antiepileptics, antipsychotics, antidepressants, anxiolytics and neuroprotective lines.
General & OTC
Analgesics, vitamins, wound-care, nutritionals — 1,283 SKUs, our broadest catalogue.
Molecule, volume, target buyer. One working day to a quote.
Your enquiry goes directly to the account manager responsible for Qatar. No call-centre hops, no generic autoresponders, just the answer your procurement file needs.
Start a Qatar enquiry → Back to all markets